Nuclear Medicine Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

CHAPTER 1. Industry Overview of Nuclear Medicine Market

1.1. Definition and Scope

1.1.1. Definition of Nuclear Medicine

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Nuclear Medicine Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Nuclear Medicine Market By Product Type

1.2.3. Nuclear Medicine Market By Application

1.2.4. Nuclear Medicine Market By End-use

1.2.5. Nuclear Medicine Market By Region

 

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

 

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.1.3. Driver 3

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.2.3. Restraint 3

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.3.3. Opportunity 3

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Nuclear Medicine Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Nuclear Medicine Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2023

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

 

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023

4.2. R&D Status of Major Manufacturers in 2023

 

CHAPTER 5. Nuclear Medicine Market By Product Type

5.1. Introduction

5.2. Nuclear Medicine Revenue By Product Type

5.2.1. Nuclear Medicine Revenue (USD Billion) and Forecast, By Product Type, 2020-2032

5.2.2. Diagnostic Products

5.2.2.1. Diagnostic Products Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2. SPECT

5.2.2.2.1. SPECT Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2.2. TC-99m

5.2.2.2.2.1. TC-99m Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2.3. TL-201

5.2.2.2.3.1. TL-201 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2.4. Other SPECT products

5.2.2.2.4.1. Other SPECT products Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3. PET

5.2.2.3.1. PET Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3.2. F-18

5.2.2.3.2.1. F-18 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3.3. SR-82/RB-82

5.2.2.3.3.1. SR-82/RB-82 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3.4. Other PET products

5.2.2.3.4.1. Other PET products Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Therapeutic Products

5.2.3.1. Therapeutic Products Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.2. Alpha Emitters

5.2.3.2.1. Alpha Emitters Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.2.2. RA-223

5.2.3.2.2.1. RA-223 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.2.3. Other alpha emitters

5.2.3.2.3.1. Other alpha emitters Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3. Beta Emitters

5.2.3.3.1. Beta Emitters Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3.2. I-131

5.2.3.3.2.1. I-131 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3.3. Y-90

5.2.3.3.3.1. Y-90 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3.4. SM-153

5.2.3.3.4.1. SM-153 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3.5. Re-186

5.2.3.3.5.1. Re-186 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3.6. Lu-117

5.2.3.3.6.1. Lu-117 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3.7. Other beta emitters

5.2.3.3.7.1. Other beta emitters Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.4. Brachytherapy

5.2.3.4.1. Brachytherapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.4.2. Cesium-131

5.2.3.4.2.1. Cesium-131 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.4.3. Iodine-125

5.2.3.4.3.1. Iodine-125 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.4.4. Palladium-103

5.2.3.4.4.1. Palladium-103 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.4.5. Iridium-192

5.2.3.4.5.1. Iridium-192 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.4.6. Other brachytherapy products

5.2.3.4.6.1. Other brachytherapy products Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

 

CHAPTER 6. Nuclear Medicine Market By Application

6.1. Introduction

6.2. Nuclear Medicine Revenue By Application

6.2.1. Nuclear Medicine Revenue (USD Billion) and Forecast, By Application, 2020-2032

6.2.2. Cardiology

6.2.2.1. Cardiology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Neurology

6.2.3.1. Neurology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Oncology

6.2.4.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5. Thyroid

6.2.5.1. Thyroid Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6. Lymphoma

6.2.6.1. Lymphoma Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.7. Bone Metastasis

6.2.7.1. Bone Metastasis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.8. Endocrine Tumor

6.2.8.1. Endocrine Tumor Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.9. Others

6.2.9.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

 

CHAPTER 7. Nuclear Medicine Market By End-use

7.1. Introduction

7.2. Nuclear Medicine Revenue By End-use

7.2.1. Nuclear Medicine Revenue (USD Billion) and Forecast, By End-use, 2020-2032

7.2.2. Hospitals

7.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Diagnostic Centers

7.2.3.1. Diagnostic Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Others

7.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

 

CHAPTER 8. North America Nuclear Medicine Market By Country 

8.1. North America Nuclear Medicine Market Overview

8.2. U.S.

8.2.1. U.S. Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

8.2.2. U.S. Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

8.2.3. U.S. Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

8.3. Canada

8.3.1. Canada Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

8.3.2. Canada Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

8.3.3. Canada Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

8.4. North America PEST Analysis

 

CHAPTER 9. Europe Nuclear Medicine Market By Country

9.1. Europe Nuclear Medicine Market Overview

9.2. U.K.

9.2.1. U.K. Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.2.2. U.K. Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

9.2.3. U.K. Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

9.3. Germany

9.3.1. Germany Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.3.2. Germany Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

9.3.3. Germany Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

9.4. France

9.4.1. France Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.4.2. France Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

9.4.3. France Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

9.5. Spain

9.5.1. Spain Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.5.2. Spain Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

9.5.3. Spain Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.6.2. Rest of Europe Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

9.6.3. Rest of Europe Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

9.7. Europe PEST Analysis

 

CHAPTER 10. Asia Pacific Nuclear Medicine Market By Country

10.1. Asia Pacific Nuclear Medicine Market Overview

10.2. China

10.2.1. China Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.2.2. China Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

10.2.3. China Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

10.3. Japan

10.3.1. Japan Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.3.2. Japan Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

10.3.3. Japan Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

10.4. India

10.4.1. India Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.4.2. India Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

10.4.3. India Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

10.5. Australia

10.5.1. Australia Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.5.2. Australia Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

10.5.3. Australia Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

10.6. South Korea

10.6.1. South Korea Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.6.2. South Korea Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

10.6.3. South Korea Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.7.2. Rest of Asia-Pacific Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

10.7.3. Rest of Asia-Pacific Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

10.8. Asia Pacific PEST Analysis

 

CHAPTER 11. Latin America Nuclear Medicine Market By Country

11.1. Latin America Nuclear Medicine Market Overview

11.2. Brazil

11.2.1. Brazil Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.2.2. Brazil Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

11.2.3. Brazil Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

11.3. Mexico

11.3.1. Mexico Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.3.2. Mexico Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

11.3.3. Mexico Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.4.2. Rest of Latin America Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

11.4.3. Rest of Latin America Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

11.5. Latin America PEST Analysis

 

CHAPTER 12. Middle East & Africa Nuclear Medicine Market By Country 

12.1. Middle East & Africa Nuclear Medicine Market Overview

12.2. GCC

12.2.1. GCC Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

12.2.2. GCC Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

12.2.3. GCC Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

12.3. South Africa

12.3.1. South Africa Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

12.3.2. South Africa Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

12.3.3. South Africa Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Nuclear Medicine Revenue (USD Billion) and Forecast By Product Type, 2020-2032

12.4.2. Rest of Middle East & Africa Nuclear Medicine Revenue (USD Billion) and Forecast By Application, 2020-2032

12.4.3. Rest of Middle East & Africa Nuclear Medicine Revenue (USD Billion) and Forecast By End-use, 2020-2032

12.5. Middle East & Africa PEST Analysis

 

CHAPTER 13. Player Analysis Of Nuclear Medicine Market

13.1. Nuclear Medicine Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2.  New Product Launches and New Product Enhancements

13.2.3. Mergers And Acquisition In Global Nuclear Medicine Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

 

CHAPTER 14. Company Profile

14.1. Advanced Accelerator Applications

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Billion), 2023

14.1.3.2. Advanced Accelerator Applications, 2023 Nuclear Medicine Business Regional Distribution

14.1.4.  Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. JSC Isotope

14.3. Bracco Imaging

14.4. Bayer AG

14.5. Eczacibasi-Monrol Nuclear Products

14.6. Nordion

14.7. GE Healthcare

14.8. Lantheus Medical Imaging

14.9. Cardinal Health

14.10. NTP Radioisotopes